Effect of Electro-Acupuncture on Blood Pressure
Neural Mechanism of the Effect of Acupuncture on Hypertension
1 other identifier
interventional
160
1 country
2
Brief Summary
Based on previous published research in animals and human, the investigators hypothesize that electroacupuncture (EA) will have a positive effect on hypertension.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hypertension
Started Feb 2003
Longer than P75 for not_applicable hypertension
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2003
CompletedFirst Submitted
Initial submission to the registry
July 1, 2009
CompletedFirst Posted
Study publicly available on registry
July 3, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
April 15, 2025
April 1, 2025
24.6 years
July 1, 2009
April 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
blood pressure
evaluation of systolic and diastolic blood pressures changes
8 weeks
Secondary Outcomes (3)
Heart rate
8 weeks
plasma catecholamine
8 weeks
plasma renin
8 weeks
Study Arms (2)
Electro-acupuncture control
EXPERIMENTALBlood pressure will be recorded before and after each EA treatment for 8 weeks. The course is a once a week 8-week treatment. Intervention is the Electro-acupuncture control treatment.
Electro-acupuncture test
EXPERIMENTALBlood pressure will be recorded before and after each EA treatment for 8 weeks. The course is a once a week 8-week treatment. Intervention is the active Electro-acupuncture treatment.
Interventions
First visit, blood pressure monitoring for 60 minutes at rest, then monitoring for subsequent 24 hours to measure BP and heart rate. At next 6-8 visits, Electro-acupuncture (EA) treatment for 30 minutes will be administered. BP and heart rate measurements will be taken 30 minutes before and after EA.
First visit, blood pressure monitoring for 60 minutes at rest, then monitoring for subsequent 24 hours to measure BP and heart rate. At next 6-8 visits, Electro-acupuncture (EA) treatment for 30 minutes will be administered. BP and heart rate measurements will be taken 30 minutes before and after EA. At end of 8-week treatment, 24 hours blood pressure and heart rate will be measured.
Eligibility Criteria
You may qualify if:
- Patients with mild coronary disease, and no significant ECG change reflecting ischemia at rest.
- Patients with high blood pressure with or without antihypertensive medication.
You may not qualify if:
- Pregnant or nursing women
- Individuals with severe coronary disease (continuous angina)
- Conduction abnormalities on ECG consistent with left bundle branch block
- Cardiac arrhythmias associated with low blood pressure (90 mmHg)
- Peripheral vascular disease
- Orthopedic disease
- Diabetic or psychological illness that could interfere with safe performance of exercise of psychophysiological stress testing
- Those with known sensitivity to topical preparations or strong reactions to medical dressings and skin tapes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Susan Samueli Integrative Health Institute
Irvine, California, 92617, United States
UCIMedical Center
Orange, California, 92868, United States
Related Publications (1)
Li P, Tjen-A-Looi SC, Cheng L, Liu D, Painovich J, Vinjamury S, Longhurst JC. Long-Lasting Reduction of Blood Pressure by Electroacupuncture in Patients with Hypertension: Randomized Controlled Trial. Med Acupunct. 2015 Aug 1;27(4):253-266. doi: 10.1089/acu.2015.1106.
PMID: 26392838BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shaista Malik, MD, PhD, MPH
University of California, Irvine
- PRINCIPAL INVESTIGATOR
Liang-Wu Fu, MD, PhD
University of California, Irvine
- PRINCIPAL INVESTIGATOR
LiFang Xie, PhD, LAc
University of California, Irvine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The care provider or acupuncturist does not know the outcome of the treatment. The investigator does not know the participants and the outcome of the study. The outcome assessor does not know the participants.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 1, 2009
First Posted
July 3, 2009
Study Start
February 1, 2003
Primary Completion (Estimated)
September 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
April 15, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share